/

Artivion, Inc.

CYL GS

CYL GSArtivion, Inc.

STUTTGART

- -

EUR

- -

Next Earnings

May 2

Ex-Dividend Date

December 9

Held by Insiders

5.31%

Held by Institutions

87.91%

Short % of Float

6.54%

Stock Chart Unavailable

Capital Structure

FRC

•

in mil. unless spec.

ST Debt

LT Borrowings

LT Finance Leases

Preferred Equity and Hybrid Capital

Shares Outstanding

Market Capitalization

Working Capital

FRC

•

in mil. unless spec.

Total Current Assets

Cash, Cash Equivalents & STI

Accounts Receivable, Net

Inventories

Total Current Liabilities

Payables & Accruals

ST Debt

Deferred Revenue

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

- -

Net Income, GAAP

- -

Free Cash Flow

- -

Total Cash Common Dividend

- -

Total Equity

- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

-Infinity

- -

-Infinity

- -

-Infinity

- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

-Infinity

- -

-Infinity

- -

-Infinity

- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

-Infinity

- -

-Infinity

- -

-Infinity

- -

Company Description

CEO: Mr. James Patrick Mackin
Full Time Employees: 1,500
Sector: Healthcare
Industry: Medical Devices
Address: 1655 Roberts Boulevard N.W. Kennesaw GA United States 30144
IPO Date: Feb 12, 1993
Website: artivion.com
Business: Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Company News

Zacks
9 days ago
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?
Yahoo Finance
9 days ago
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?
Yahoo Finance
9 days ago
Shareholders Will Probably Hold Off On Increasing Artivion, Inc.'s (NYSE:AORT) CEO Compensation For The Time Being
GuruFocus.com
10 days ago
Artivion Inc (AORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic Advances
GuruFocus.com
10 days ago
Q1 2024 Artivion Inc Earnings Call Transcript
Zacks
11 days ago
Artivion (AORT) Tops Q1 Earnings and Revenue Estimates
GuruFocus.com
11 days ago
Artivion Inc (AORT) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
Yahoo Finance
11 days ago
Artivion Reports First Quarter 2024 Financial Results
GuruFocus.com
18 days ago
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting
Yahoo Finance
18 days ago
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting
Yahoo
18 days ago
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting
GuruFocus.com
25 days ago
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
Yahoo Finance
25 days ago
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
Yahoo
25 days ago
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
Yahoo Finance
a month ago
Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year
Yahoo
a month ago
Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year
Zacks
a month ago
Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
Tipranks
a month ago
Artivion’s Growth Trajectory: A Buy Rating Amidst Promising Aortic Products and Financial Upswing
tipranks.com
a month ago
Artivion’s Growth Trajectory: A Buy Rating Amidst Promising Aortic Products and Financial Upswing
Yahoo
2 months ago
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Company Description

CEO: Mr. James Patrick Mackin
Full Time Employees: 1,500
Sector: Healthcare
Industry: Medical Devices
Address: 1655 Roberts Boulevard N.W. Kennesaw GA United States 30144
IPO Date: Feb 12, 1993
Website: artivion.com
Business: Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Company News

Zacks
9 days ago
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?
Yahoo Finance
9 days ago
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?
Yahoo Finance
9 days ago
Shareholders Will Probably Hold Off On Increasing Artivion, Inc.'s (NYSE:AORT) CEO Compensation For The Time Being
GuruFocus.com
10 days ago
Artivion Inc (AORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic Advances
GuruFocus.com
10 days ago
Q1 2024 Artivion Inc Earnings Call Transcript
Zacks
11 days ago
Artivion (AORT) Tops Q1 Earnings and Revenue Estimates
GuruFocus.com
11 days ago
Artivion Inc (AORT) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
Yahoo Finance
11 days ago
Artivion Reports First Quarter 2024 Financial Results
GuruFocus.com
18 days ago
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting
Yahoo Finance
18 days ago
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting
Yahoo
18 days ago
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting
GuruFocus.com
25 days ago
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
Yahoo Finance
25 days ago
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
Yahoo
25 days ago
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
Yahoo Finance
a month ago
Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year
Yahoo
a month ago
Artivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last year
Zacks
a month ago
Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
Tipranks
a month ago
Artivion’s Growth Trajectory: A Buy Rating Amidst Promising Aortic Products and Financial Upswing
tipranks.com
a month ago
Artivion’s Growth Trajectory: A Buy Rating Amidst Promising Aortic Products and Financial Upswing
Yahoo
2 months ago
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference